American Journal of Cardiology
Volume 98, Issue 10 , Pages 1340-1344 , 15 November 2006

Intravascular Brachytherapy Versus Drug-Eluting Stents for the Treatment of Patients With Drug-Eluting Stent Restenosis

  • Rebecca Torguson, BS

      Affiliations

    • Division of Cardiology, Washington Hospital Center, Washington, DC
    • ,
  • Manel Sabate, MD

      Affiliations

    • Clinico San Carlos, Madrid, Spain.
    • ,
  • Regina Deible, RN

      Affiliations

    • Division of Cardiology, Washington Hospital Center, Washington, DC
    • ,
  • Kimberly Smith, BS

      Affiliations

    • Division of Cardiology, Washington Hospital Center, Washington, DC
    • ,
  • William W. Chu, MD, PhD

      Affiliations

    • Division of Cardiology, Washington Hospital Center, Washington, DC
    • ,
  • Kenneth M. Kent, MD

      Affiliations

    • Division of Cardiology, Washington Hospital Center, Washington, DC
    • ,
  • Augusto D. Pichard, MD

      Affiliations

    • Division of Cardiology, Washington Hospital Center, Washington, DC
    • ,
  • William O. Suddath, MD

      Affiliations

    • Division of Cardiology, Washington Hospital Center, Washington, DC
    • ,
  • Lowell F. Satler, MD

      Affiliations

    • Division of Cardiology, Washington Hospital Center, Washington, DC
    • ,
  • Ron Waksman, MD

      Affiliations

    • Division of Cardiology, Washington Hospital Center, Washington, DC
    • Corresponding Author InformationCorresponding author: Tel: 202-877-2812; fax: 202-877-2715.

Received 9 March 2006 ,Revised 7 June 2006 ,Accepted 7 June 2006.

References 

  1. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, et al Randomized Study with the Sirolimus-Coated Bx Velocity Balloon-Expandable Stent in the Treatment of Patients with de Novo Native Coronary Artery Lesions (A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization). N Engl J Med. 2002;346:1773–1780
  2. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O’Shaughnessy C, et al Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349:1315–1323
  3. Stone GW, Ellis SG, Cox DA, Hermiller J, O’Shaughnessy C, Mann JT, et al A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004;350:221–231
  4. Schofer J, Schluter M, Gershlick AH, Wijns W, Garcia E, Schampaert E, et al. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS). Lancet. 2003;362:1093–1099
  5. Costa M, Angiolillo DJ, Teirstein P, Gilmore P, Leon M, Moses J, et al. Sirolimus-eluting stents for treatment of complex bypass graft disease: insights from the SECURE registry. J Invasive Cardiol. 2005;17:396–398
  6. Lemos PA, Serruys PW, van Domburg RT, Saia F, Arampatzis CA, Hoye A, et al Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the “real world”: the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry. Circulation. 2004;109:190–195
  7. Windecker S, Remondino A, Eberli FR, Juni P, Raber L, Wenaweser P, et al Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. N Engl J Med. 2005;353:653–662
  8. Dibra A, Kastrati A, Mehilli J, Pache J, Schühlen H, von Beckerath N, et al. Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients. N Engl J Med. 2005;353:663–670
  9. Stone GW, Ellis SG, O’Shaughnessy CD, Martin SC, Satler L, McGarry T, et al. Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial. JAMA. 2006;295:1253–1263
  10. Waksman R, White RL, Chan RC, Bass BG, Geirlach L, Mintz GS, et al Intracoronary gamma-radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis. Circulation. 2000;101:2165–2171
  11. Waksman R, Ajani AE, White RL, Chan RC, Satler LF, Kent KM, et al Intravascular gamma radiation for in-stent restenosis in saphenous-vein bypass grafts. N Engl J Med. 2002;346:1194–1199
  12. Leon MB, Teirstein PS, Moses JW, Tripuraneni P, Lansky AJ, Jani S, et al Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting. N Engl J Med. 2001;344:250–256
  13. Popma JJ, Suntharalingam M, Lansky AJ, Heuser RR, Speiser B, Teirstein PS, et al Randomized trial of 90Sr/90Y beta-radiation versus placebo control for treatment of in-stent restenosis. Circulation. 2002;106:1090–1096
  14. Kastrati A, Schomig A, Elezi S, Schuhlen H, Dirschinger J, Hadamitzky M, et al. Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol. 1997;30:1428–1436
  15. Costa MA, Simon DI. Molecular basis of restenosis and drug-eluting stents. Circulation. 2005;111:2257–2273
  16. Lemos PA, Saia F, Ligthart JM, Arampatzis CA, Sianos G, Tanabe K, et al Coronary restenosis after sirolimus-eluting stent implantation: morphological description and mechanistic analysis from a consecutive series of cases. Circulation. 2003;108:257–260
  17. Colombo A, Orlic D, Stankovic G, Corvaja N, Spanos V, Montorfano M, et al. Preliminary observations regarding angiographic pattern of restenosis after rapamycin-eluting stent implantation. Circulation. 2003;107:2178–2180
  18. Lemos PA, van Mieghem CAG, Arampatzis CA, Hoye A, Ong ATL, McFadden E, et al. Post-sirolimus-eluting stent restenosis treated with repeat percutaneous intervention: late angiographic and clinical outcomes. Circulation. 2004;109:2500–2502
  19. Degertekin M, Regar E, Tanabe K, Smits PC, van der Giessen WJ, Carlier SG, et al Sirolimus-eluting stent for treatment of complex in-stent restenosis: the first clinical experience. J Am Coll Cardiol. 2003;41:184–189
  20. Sousa JE, Costa MA, Abizaid A, Sousa AG, Feres F, Mattos LA, et al Sirolimus-eluting stent for the treatment of in-stent restenosis: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation. 2003;107:24–27
  21. Dilcher C, Chan R, Hellinga D, Seabron R, Pakala R, Kuchulakanti PK, et al. Effect of ionizing radiation on the stability and performance of the TAXUS Express(2) paclitaxel-eluting stent. Cardiovasc Radiat Med. 2004;5:136–141
  22. Holmes DR, Teirstein P, Satler L, Sketch M, O’Malley J, Popma JJ, et al. Sirolimus-eluting stents vs vascular brachytherapy for in-stents restenosis within bare-metal stents: the SISR randomized trial. JAMA. 2006;295:1307–1309
  23. Chu WW, Torguson R, Pichard AD, Satler LF, Chan R, Porrazzo M, et al. Drug-eluting stents versus repeat vascular brachytherapy for patients with recurrent in-stent restenosis after failed intracoronary radiation. J Invasive Cardiol. 2005;17:659–662

PII: S0002-9149(06)01510-4

doi: 10.1016/j.amjcard.2006.06.027

American Journal of Cardiology
Volume 98, Issue 10 , Pages 1340-1344 , 15 November 2006

Article Tools